Hechemy K E, Rubin B B
J Clin Microbiol. 1983 Mar;17(3):489-92. doi: 10.1128/jcm.17.3.489-492.1983.
In correlating results obtained from a new latex-Rickettsia rickettsii test with results obtained from a reference microimmunofluorescence test for Rocky Mountain spotted fever, we found that for seropositive patients each microimmunofluorescence titer (up to 4,096) was usually double the median titer obtained from the latex-R. rickettsii test. The pattern of immunoserological response indicated that latex-R. rickettsii is reactive with sera containing either anti-R. rickettsii immunoglobulin M (IgM) or IgG or both. The agglutination efficiency of the new test was greater when the anti-rickettsial IgM/IgG ratio was greater than or equal to 1. Sera from late-convalescent patients were generally minimally reactive or nonreactive in the latex-R. rickettsii test unless anti-R. rickettsii IgM was present.
在将新型立氏立克次体乳胶试验所得结果与落基山斑疹热参考微量免疫荧光试验所得结果进行对比时,我们发现,对于血清学阳性患者,每种微量免疫荧光滴度(最高达4096)通常是立氏立克次体乳胶试验所得中位数滴度的两倍。免疫血清学反应模式表明,立氏立克次体乳胶与含有抗立氏立克次体免疫球蛋白M(IgM)或IgG或两者的血清发生反应。当抗立克次体IgM/IgG比率大于或等于1时,新试验的凝集效率更高。除非存在抗立氏立克次体IgM,否则恢复期晚期患者的血清在立氏立克次体乳胶试验中通常反应极小或无反应。